Skip to main content
Figure 3 | Cost Effectiveness and Resource Allocation

Figure 3

From: Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patients

Figure 3

Weights for MCDA Value Matrix components and scores for growth hormone for Turner syndrome in Canada (average data from eight panelists). *A five point weighting scale was used with 1 lowest and 5 highest weight. **A short four point scoring scale was used with 0 lowest (to account for component that would not bring any value) and 3 highest score.

Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us